(A) Average number of trials per session divided by the baseline number of trials for ‘between reach’ stimulation. Gray lines represent individual rats. Linear mixed model: effect of laser: t(79) = 1.13, p=0.26; interaction between laser and session: t(584) = −0.64, p=0.52. (B) Average first attempt success rate divided by baseline success rate for ‘between reach’ stimulation. Linear mixed model: effect of laser: t(133) = −0.29, p=0.78; interaction between laser and session: t(584) = −0.94, p=0.35. (C) Moving average of success rate within individual sessions in the last retraining session, first 5 ‘laser on’ sessions, and first 5 ‘occlusion’ sessions. ‘R10’, ‘L1’, ‘O1’, etc. indicate the 10th retraining session, first ‘laser on’ session, first ‘occlusion’ session, etc. ‘During reach’ data from Figure 2 are shown for comparison. Unlike panel B, these are not normalized to retraining sessions because they are within-session moving averages. Black bars represent trials with a statistically significant difference between groups (Wilcoxon rank sum text, p<0.01). Data for individual rats are shown in Figure 3—figure supplement 1. Figure 3—figure supplement 2 shows additional performance measures for ‘between reach’ ChR2 activation (‘any reach’ success rates, number of attempts per trial, and breakdown of reach outcomes across sessions). Shaded colored areas in C and error bars in A-B represent s.e.m.
Figure 3—source data 1. A .mat file containing number of trials (num_trials) and first reach success rate (firstReachSuccess) for 22 testing sessions (‘retraining’, ‘laser on’, and ‘occluded’).Data is average per session for each rat. The field ‘experimentInfo’ provides information on groups.
Figure 3—source data 2. A .mat file containing first reach success rate averages across a moving block of 10 trials for 22 testing sessions (‘retraining’, ‘laser on’, and ‘occluded’).The field ‘exptInfo’ provides information on groups.
Figure 3—source data 3. Statistics.A .xlsx file containing the statistical output of Wilcoxon ranksum tests for comparisons between ChR2 During and ChR2 Between group averages in
Figure 3C.